Utilizing Engineered E. Coli as An Asymmetric Biocatalyst towards Pharmaceutical Precursors

Document Type

Presentation

Presentation Date

1-1-2009

Abstract or Description

This presentation was given at SERMACS.

Sponsorship/Conference/Institution

SERMACS

Location

San Juan, Puerto Rico

This document is currently not available here.

Share

COinS